Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?
HIV Med
.
2023 Jun;24(6):760-761.
doi: 10.1111/hiv.13456.
Epub 2023 Jan 2.
Authors
Maria Mazzitelli
1
2
,
Emanuele Foca'
3
,
Mattia Prosperi
4
,
Roberto Cauda
5
6
,
Damiano Farinacci
6
,
Valentina Iannone
6
,
Francesco Castelli
3
,
Canio Carriero
3
,
Angelo Pan
7
,
Annalisa Saracino
8
,
Carlo Torti
9
,
Eugenia Quiros-Roldan
3
Affiliations
1
Infectious and Tropical Disease Unit, Padua University Hospital, Padua, Italy.
2
University Hospital of Padua, Padua, Italy.
3
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
4
Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
5
Catholic University of the Sacred Heart, Rome, Italy.
6
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
7
Infectious and Tropical Diseases Unit of Cremona, Cremona, Italy.
8
Clinic of Infectious Diseases, Policlinico Hospital of Bari, Bari, Italy.
9
Infectious and Tropical Diseases Unit, Magna Graecia University of Catanzaro, Catanzaro, Italy.
PMID:
36593693
DOI:
10.1111/hiv.13456
No abstract available
Publication types
Letter
MeSH terms
Early Detection of Cancer
HIV Infections* / complications
Humans
Liver Cirrhosis / diagnosis
Male
Mass Screening
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnosis
Substances
Prostate-Specific Antigen